Description
Actrapid FlexPen 100 IU/ml Solution for Injection is a rapid-acting insulin designed to control blood sugar levels in individuals with diabetes. Manufactured by Novo Nordisk, this pre-filled, disposable pen delivers 1–60 units per injection and is ideal for patients requiring precise dosing. The insulin begins to lower blood glucose within 30 minutes of subcutaneous injection, peaks in 1.5 to 3.5 hours, and continues to act for approximately 7 to 8 hours. It is commonly used in combination with intermediate or long-acting insulins to provide comprehensive blood sugar control. Patients should administer Actrapid FlexPen 20–30 minutes before meals and rotate injection sites to minimize the risk of lipodystrophy. Common side effects include hypoglycemia, injection site reactions, and weight gain
 10 ML.jpeg)
Change Language